German Minister backs e-pharmacy, e-Rxs

17 May 2001

German Health Minister Ulla Schmidt is backing on-line pharmacies andelectronic prescribing. She told an economics forum of the German pharmacy association, the DAV, that Internet trading in prescription-only drugs should be made possible, and that e-commerce could not be dismissed, especially as it would enable health fund costs to be reduced.

Drug distribution via pharmacies is too expensive, she said, noting that Internet trading had long been allowed in the UK and the Netherlands. The controversy over Internet pharmacies was fuelled by the sale of drugs into Germany through the Dutch DocMorris.com pharmacy site (Marketletter January 22), with German pharmacists expressing concern over patient safety and their sales. Ms Schmidt also supports a system of e-scripts which, she said, would enable the industry, health funds and pharmacists to reduce costs and simplify procedures. Doctors would prescribe digitally, with data transmitted directly to the health funds.

The Federation of German Pharmacy Associations, the ABDA, plans to launch an Internet site in the summer, where patients will be able to obtain information and order medicines which would then be collected from their local pharmacies.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight